Treat Cancer In India

Palliative Care and Advanced Cancer in Zimbabwe: Options, Rights & Treatment in India 2025

Advanced cancer in Zimbabwe is not the end of options. Learn what palliative care exists in Zimbabwe, which disease-modifying treatments in India can extend life with stage 4 cancer, and how to make informed decisions for your family.

Fungai had been told, gently but clearly, that there was nothing more to be done.

She was 52, diagnosed with stage four cervical cancer that had spread to her lungs and liver. Her oncologist at Parirenyatwa Hospital in Harare had tried to find options within Zimbabwe's system. There were none that would change the outcome, she was told. The focus now should be on managing her symptoms and keeping her comfortable.

She accepted this. Her family accepted this. For three weeks, they believed it was the full picture.

Then her daughter, searching online at midnight, found something she had not known existed: that in India, immunotherapy was being used for metastatic cervical cancer — pembrolizumab, for patients whose tumours express a certain protein — and that some patients with stage four disease had experienced what oncologists cautiously describe as durable responses. Not cure. But months, sometimes years, of disease control. Quality of life. Time.

The full picture, it turned out, was larger than the frame Zimbabwe's system could offer.

Fungai went to India. She received pembrolizumab. Eight months later, her lung lesions had shrunk significantly. She was not cured. She knew that. But she was alive, functional, and spending time with her family in a way that had seemed impossible in the three weeks when she believed there was nothing more to be done.

This article is for every Zimbabwean family who has been told that sentence — there is nothing more to be done — and needs to understand what it actually means, what it does not mean, and what options genuinely exist both within Zimbabwe and beyond it.

---

What Does "Advanced Cancer" Actually Mean?

The term "advanced cancer" is used in two related but distinct ways, and the distinction matters enormously for understanding what options exist.

Locally advanced cancer means cancer that has grown significantly in its original location — perhaps involving nearby lymph nodes or adjacent structures — but has not spread to distant organs. Locally advanced disease is often still treatable with curative intent. Stage three cancers are typically in this category.

Metastatic cancer — sometimes called stage four — means cancer that has spread to distant organs: the liver, lungs, bones, brain, or other sites. This is what most people mean when they say "advanced cancer." Metastatic disease is typically not curable with current medical science — with some exceptions, including certain types of blood cancer, testicular cancer, and some lymphomas. But not curable is not the same as not treatable.

This distinction is the most important thing this article communicates. In oncology, treatment goals exist on a spectrum:

Curative intent: Treatment aimed at eliminating the cancer completely.

Disease-modifying treatment: Treatment that cannot cure the cancer but can shrink it, slow its growth, and extend life — sometimes significantly. Chemotherapy, targeted therapy, immunotherapy, and hormonal therapy can all serve this purpose.

Palliative treatment: Treatment aimed at managing symptoms, reducing pain, and maintaining quality of life — without being primarily directed at the cancer itself. Palliative radiotherapy to shrink a painful bone metastasis is an example.

Best supportive care: Comprehensive management of symptoms, psychological distress, spiritual needs, and family support — without any cancer-directed treatment.

When a Zimbabwean oncologist tells a patient that "there is nothing more to be done," they are almost always communicating something specific to the resources available within Zimbabwe's system. They are not communicating a global medical verdict. In most cases, disease-modifying treatment options exist — in India, in particular — that are simply outside what Zimbabwe can provide.

Understanding this distinction does not mean pursuing treatment at all costs regardless of burden and quality of life. It means making an informed choice — with full knowledge of what exists — rather than accepting a constraint of the local system as a universal truth.

---

Palliative Care in Zimbabwe: What Exists Right Now

Before discussing what lies beyond Zimbabwe's borders, it is essential to understand what palliative care exists within them — because for some families, what is available in Zimbabwe is the right answer, and every Zimbabwean cancer patient deserves to know what they are entitled to.

The National Palliative Care Programme

Zimbabwe has a national palliative care programme that is, by the standards of sub-Saharan Africa, relatively well-developed. The country was an early adopter of integrating palliative care into its healthcare system and has developed policy frameworks and trained healthcare workers specifically in this area.

Palliative care services in Zimbabwe operate at several levels:

Hospital-based palliative care: Parirenyatwa Group of Hospitals in Harare and Mpilo Central Hospital in Bulawayo both have palliative care teams. These teams include doctors, nurses, and social workers trained in pain management, symptom control, psychological support, and family counselling.

The Island Hospice and Healthcare: Based in Harare, Island Hospice is Zimbabwe's oldest and most established palliative care organisation. Founded in 1979, it provides home-based palliative care services to patients in Harare and the surrounding area. It offers nursing care, social work support, counselling, and bereavement support for families. Island Hospice's services are provided on a sliding-scale fee basis — no patient is turned away for inability to pay.

Hospice and Palliative Care Association of Zimbabwe (HOSPAZ): The national association coordinating palliative care services across Zimbabwe, HOSPAZ works to improve access to palliative care and pain management across the country. It can direct patients and families to the nearest available palliative care services in their province.

Zimbabwe Rural Palliative Care Initiative (PCI-Z): A programme specifically designed to extend palliative care services into rural areas — where most Zimbabweans live and where formal palliative care has historically been hardest to access. PCI-Z integrates palliative care into community home-based care teams already operating in rural areas.

Faith-based hospices: Several churches and faith-based organisations operate small hospice facilities and home-based care services across Zimbabwe. These vary in capacity and services offered but are often the most accessible option in smaller towns and rural areas.

Oral Morphine: The Cornerstone of Pain Management

One of the most important palliative care achievements in Zimbabwe is the availability of oral morphine for cancer pain management at public health facilities. Zimbabwe is one of the few countries in sub-Saharan Africa with a functioning oral morphine programme that reaches below tertiary hospital level.

Pain is the symptom most feared by cancer patients and families — and morphine, when properly prescribed and managed, is extraordinarily effective at controlling cancer pain. Its availability in Zimbabwe means that patients with advanced cancer do not have to endure unmanaged pain as the default experience.

If you or a family member with advanced cancer is experiencing significant pain and has not been prescribed adequate analgesia, ask specifically: "Is oral morphine available for cancer pain management at this facility?" At Parirenyatwa, Mpilo, Island Hospice, and a growing number of district hospitals, the answer should be yes.

What Palliative Care in Zimbabwe Cannot Always Provide

Palliative care in Zimbabwe is a genuine and meaningful resource — but it has significant limitations that families need to understand.

Geographic inequity: Island Hospice serves Harare. Services in Bulawayo are more limited. Outside these two cities, access to specialist palliative care falls sharply. Rural patients face the greatest gaps.

Insufficient psychological and psychiatric support: Cancer carries an enormous psychological burden — anxiety, depression, existential distress, family system disruption. Dedicated psychological support within Zimbabwe's palliative care system is limited. Individual counsellors exist at island Hospice and some hospital programmes, but demand significantly exceeds capacity.

Limited disease-modifying treatment within the palliative framework: Zimbabwe's palliative care system is primarily supportive — it manages symptoms and supports families, but it does not have access to the newer palliative disease-modifying treatments (immunotherapy, targeted therapy) that can extend life with advanced cancer. These are not considered palliative care per se — they are oncological treatment — but in the context of stage four disease, they serve a palliative function by controlling the cancer and improving quality of life.

Inconsistent opioid access at district and rural level: While oral morphine is available at major hospitals, access at district and rural level remains inconsistent. Patients in smaller towns and rural areas sometimes struggle to maintain consistent pain management.

---

Disease-Modifying Treatment for Advanced Cancer: What India Offers That Zimbabwe Cannot

For Zimbabwean patients with metastatic cancer who have been told that curative treatment is no longer possible, the relevant question becomes: what treatment can slow the disease, manage symptoms, and extend life with acceptable quality?

The answer to that question looks very different in India than it does in Zimbabwe.

Immunotherapy for Metastatic Cancer

Immunotherapy — specifically immune checkpoint inhibitors — represents one of the most significant advances in oncology of the past decade. These drugs work by releasing the immune system's natural brakes, allowing it to recognise and attack cancer cells.

For advanced cancer patients, immunotherapy has transformed the treatment landscape for multiple cancer types that were previously considered rapidly fatal.

Pembrolizumab (Keytruda) is approved for multiple metastatic cancers including:

For patients whose tumours are eligible — determined by biomarker testing — pembrolizumab can produce responses ranging from partial shrinkage to complete remission. In a subset of patients, responses are durable — lasting years. For patients with stage four disease who have no other effective options, this is genuinely life-changing.

Pembrolizumab cost in India: USD 800 – USD 1,500 per cycle (given every 3 weeks)

Nivolumab (Opdivo) serves a similar function and is available at major Indian cancer hospitals for multiple tumour types.

These drugs are essentially unavailable within Zimbabwe's public health system. For Zimbabwean patients with advanced cancer who have not been tested for PD-L1 expression or MSI status — the biomarkers that predict response to immunotherapy — this testing alone, available at Indian hospitals, can open a treatment door that no one in Zimbabwe was aware existed.

Targeted Therapy for Advanced Cancer

Targeted therapy — drugs designed to block specific molecular pathways that cancer cells depend on for growth — has revolutionised the treatment of multiple advanced cancers.

Key examples relevant to Zimbabwean patients:

For HER2-positive metastatic breast cancer:

Trastuzumab (Herceptin), pertuzumab, T-DM1 (Kadcyla), and tucatinib can dramatically extend life in patients with HER2-positive disease that has spread to the brain, liver, and other organs. These combinations are standard of care internationally and available at Indian cancer hospitals. They are not available in Zimbabwe's public system.

For hormone receptor-positive metastatic breast cancer:

CDK4/6 inhibitors (ribociclib, palbociclib, abemaciclib) combined with hormone therapy have extended median progression-free survival in metastatic HR+ breast cancer by years compared to hormone therapy alone. A Zimbabwean woman with metastatic HR+ breast cancer who has never received a CDK4/6 inhibitor has not yet received the standard of care by international guidelines.

For advanced prostate cancer:

Enzalutamide, abiraterone, darolutamide, and the revolutionary Lutetium-177 PSMA therapy offer meaningful life extension for men with metastatic castration-resistant prostate cancer. Lutetium-177 PSMA therapy — which delivers targeted radiation directly to prostate cancer cells throughout the body using the PSMA receptor — is now available at select Indian centres and has shown significant survival benefit in clinical trials.

For advanced colorectal cancer:

Bevacizumab and cetuximab extend life in metastatic colorectal cancer. For MSI-high metastatic colorectal cancer, pembrolizumab has shown survival outcomes dramatically better than chemotherapy alone. None of these are routinely available in Zimbabwe.

For blood cancers:

Advanced leukaemia, lymphoma, and myeloma benefit from targeted agents — venetoclax for CLL and AML, ibrutinib for CLL and mantle cell lymphoma, bortezomib and lenalidomide for myeloma — and from stem cell transplantation where indicated. India's haemato-oncology centres offer the full range of these treatments, including CAR-T cell therapy for relapsed/refractory blood cancers.

[Learn more about blood cancer treatment in India for Zimbabwean patients →](https://treatcancerinindia.com/blood-cancer-treatment-india-for-zimbabwe)

Palliative Radiotherapy in India

For advanced cancer patients with specific symptoms driven by tumour burden — bone pain from metastases, bleeding from a pelvic tumour, obstruction from lymph node masses — targeted palliative radiotherapy can dramatically improve quality of life and function.

In Zimbabwe, palliative radiotherapy is available at Parirenyatwa and Mpilo but subject to equipment availability issues. In India, palliative radiotherapy is delivered on operational equipment, rapidly, with short waiting times. For a patient whose quality of life is being significantly impaired by a specific symptom that radiotherapy could address, the reliability of India's radiotherapy is itself a reason to consider the journey.

---

The Conversation About Goals of Care

One of the things Zimbabwe's palliative care training has done well — and that is worth preserving regardless of where treatment occurs — is the emphasis on goals of care conversations.

A goals of care conversation is a direct, honest discussion between a patient, their family, and their healthcare team about what the patient most wants from the time and treatment ahead. It is not a conversation about giving up. It is a conversation about making deliberate choices.

For a Zimbabwean patient with advanced cancer, the relevant questions in a goals of care conversation might be:

What matters most to you? More time, even if treatment is burdensome? The ability to be at home? Freedom from pain above all else? The chance to see a specific event — a child's graduation, a grandchild's birth?

What are you willing to go through for more time? Travel. Treatment side effects. Time away from family. Financial cost to those you love. These are real considerations and they are the patient's to weigh, not anyone else's.

What would you not want? Some patients, when fully informed, choose not to pursue aggressive treatment in India — not from lack of courage or information, but from a considered assessment that the burden of treatment is not what they want for the time they have. This is a valid and honourable choice and should be supported rather than challenged.

What would feel like a good outcome, given everything? Not a cure — but what would feel like the right use of the time and energy and resources available?

These conversations are rarely had spontaneously in Zimbabwean families. Cancer is not typically discussed openly until it becomes impossible to avoid. But families that have had them consistently describe better experiences — less crisis, less regret, more sense of control — than those that have not.

---

How to Talk About Advanced Cancer in a Zimbabwean Family

The cultural weight of a cancer diagnosis in Zimbabwe is significant. There are families in which the word "cancer" is never spoken aloud in front of the patient. Families in which extended relatives arrive and disagree loudly about treatment decisions. Families in which the patient is the last to know the full severity of their condition.

None of these dynamics are unique to Zimbabwe — they exist in every culture. But they have specific shapes in Zimbabwean families that are worth acknowledging.

The protection instinct. Many Zimbabwean families conceal the severity of a diagnosis from the patient out of love — a desire to protect them from fear. The consequence is that patients make decisions, or fail to make them, without the information they need. Most patients, when asked directly, say they want to know the truth. Not brutally, not without compassion — but the truth.

The authority of the senior family member. In many Zimbabwean families, a senior uncle, aunt, or grandparent effectively holds decision-making authority over a cancer patient's treatment — sometimes overriding the patient's own expressed wishes. Healthcare workers in Zimbabwe and Indian hospital staff with experience treating Zimbabwean patients have both noted this dynamic. It is worth the family having an honest conversation about who the decision-maker is, and whether that arrangement serves the patient's best interests.

The role of faith. Zimbabwean families are typically deeply religious, and faith plays a genuine and important role in coping with a cancer diagnosis. Prayer, church community, and the theological framework of suffering and hope are all real sources of support. This sits alongside, not instead of, seeking the best available medical care. Faith and oncology are not in competition.

Bereavement. When a Zimbabwean patient with advanced cancer dies — in Zimbabwe or in India — the family needs support that begins before the death, not after. Island Hospice offers bereavement counselling. Some churches have bereavement support programmes. If a family member dies in India, the hospital's international patient department can assist with repatriation of remains — a practical concern that Zimbabwean families sometimes do not know how to navigate and that reputable Indian hospitals have helped many families through.

---

Making the Decision: India for Advanced Cancer — Is It Right for Every Family?

No. And it is important to say that clearly.

Travelling to India for disease-modifying treatment with advanced cancer is the right choice for some Zimbabwean families and not the right choice for others. This is not a judgment on the families who choose not to go. It is a recognition that:

The financial cost is real and significant. For a family that would need to liquidate every asset and still fall short, the decision may not be feasible — and the stress of an impossible financial burden on a dying patient and their family can itself diminish quality of life in the time that remains.

The physical burden of treatment is real. Chemotherapy and immunotherapy for advanced disease have side effects. For some patients, particularly those with very advanced disease and poor performance status, the treatment burden may exceed the benefit. A good oncologist — in Zimbabwe or India — will give an honest assessment of whether a patient is fit enough for treatment to help rather than harm.

Distance from family and home has real costs. Some patients — when genuinely asked — say that they would rather spend their remaining time at home, with the people they love, in their own place, than in a hospital in a foreign country. This is a legitimate and worthy choice.

But some families, faced with the same information, will choose differently. They will find the money. They will endure the journey. They will accept the treatment burden. Because for them, the chance of more time — more real, functional time — is worth what it costs.

Both choices deserve respect. What neither choice deserves is to be made without full information.

This article, and this entire blog series, has been about one thing: making sure Zimbabwean families have the full information. So that whatever they decide, they decide it knowing what is possible — not constrained by what a broken machine, an empty pharmacy shelf, or an overstretched healthcare system was able to show them.

[Learn about advanced cancer treatment options in India for Zimbabwean patients →](https://treatcancerinindia.com/cancer-treatment-india-for-zimbabwe)

Additional resources for Zimbabwean patients:

---

A Note on Dignity

Throughout this blog series, we have written about cancer in Zimbabwe in terms of systems, statistics, and treatment options. We have written about machines that break down and drugs that run out. We have written about the gap between what Zimbabwe has and what is available elsewhere.

It is worth pausing, at the end of this series, to say something simpler.

Every Zimbabwean person living with cancer is a person. Not a case. Not a diagnosis. Not a statistic in a registry. A person with a history, a family, a set of things they love, a vision of what they hoped their life would look like.

That person deserves to know what options exist. They deserve to have their pain managed. They deserve to have their questions answered honestly. They deserve to make decisions about their own body and their own time with full information and genuine support.

They deserve dignity — in treatment, in communication, in the care they receive in whatever time they have, and in how that time ends.

That is what good palliative care offers. That is what good oncology offers. That is what this website, and this blog series, has tried to offer in the form of information.

We hope it has helped someone.

---

Fungai, Nine Months Later

She is still on pembrolizumab, administered every three weeks at a clinic in Harare that agreed to administer the drug she sources privately on the protocol her Indian oncologist designed.

Her lung lesions are stable. The liver lesion has not grown in four months.

She is not cured. She knows that. Her family knows that. Her oncologist in Chennai has been honest with her at every step.

But she spent her grandson's third birthday at her home in Harare last month. She cooked food. She held him. She was present in the way she had been told she would not be.

That is not nothing.

In the language of oncology, it is called a response.

In the language of a grandmother holding her grandson, it is called time.

And time, it turns out, was worth going to India for.

---

If you or a family member is living with advanced cancer in Zimbabwe and wants to understand what treatment and palliative options are available — in Zimbabwe and in India — [our patient support team is available for a free consultation](https://treatcancerinindia.com/cancer-treatment-india-for-zimbabwe). We support Zimbabwean patients and families from the first question through to the last appointment, with honesty, care, and the full picture of what is possible.

Related Articles

Explore Cancer Treatments in India

Breast Cancer Treatment IndiaLung Cancer Treatment IndiaBlood Cancer & Leukemia IndiaProstate Cancer IndiaBone Marrow Transplant IndiaProton Therapy IndiaRobotic Surgery IndiaImmunotherapy India

Planning cancer treatment in India? We connect international patients with top oncologists.

Get Free Cancer Treatment Consultation →